Antibacterials Flashcards

1
Q

Four Mechanisms of Actions of Antibacterials

A
  1. inhibitors of cell wall synthesis
  2. inhibitors of translation and transcription
  3. inhibition of DNA syntheses and integrity
  4. inhibitors of folate synthesis and function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inhibitors of Cell Wall Synthesis

A

beta lactams penicillins

cephalosporins

glycopeptides: vancomycin

TB medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inhibitors of Translation/Transcription

A

tetracyclines

macrolides

clindamycin

oxazolidinones: linezolid

aminoglycosides and spectinomycin

TB medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inhibition of DNA syntheses and integrity/inhibitors of folate synthesis and function

A

sulfonamides, trimethoprim

quinolones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bactericidal

A

mechanism is generally inhibit cell wall synthesis

time dependent killing

concentration dependent killing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Time Dependent Killing

A

serum level above MIC

beta lactams, vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Concentration Dependent Killing

A

higher drug concentration determines rate and extent of killing

aminoglycosides, quinolones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bacteriostatic

A

mechanism is generally inhibition of protein synthesis

tetracyclines, macrolides, sulfonamides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Postantibiotic Effect

A

persistent suppression of bacterial growth after limited exposure to an antimicrobial agent

antibiotic level falls below MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Postantibiotic Effect: Proposed Mechanisms

A

slow recovery after reversible non lethal damage to cell structures

persistence of the drug at the binding site

need to synthesize new enzymes before microorganism growth can resume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Penicillin: narrow spectrum

A

Penicillinase susceptible:

  • PCN G
  • PCN VK

Penicillinase resistant:

  • nafcillin
  • oxacillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Penicillin: wider spectrum

A

+/- penicillinase inhibitor

  • ampicillin
  • amoxicillin
  • piperacillin
  • ticarcillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What additional microorganisms are covered by amoxicillin but NOT penicillin?

A

H influenza
M catarrhalis
S aureus
Strept

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Penicillin: PK

A

rapid renal elimination

some biliary clearance (ampicillin, nafcillin)
-concern for newborns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Penicillin: ADE

A

hypersensitivity rxn

maculopapular rash (ampicllin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Penicillin: activity spectrum (narrow and wider)

A

Narrow:

  • streptococcal infections
  • staphlococcal infections
  • meningococcal infections
  • syphilis

Wider:
-gram negative bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cephalosporins: first generation

A

cephalexin

activity:

  • skin
  • soft tissue
  • UTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cephalosporins: second generation

A

cefotetan
cefoxitin
cefuroxime

activity:

  • S pneumoniae
  • H influenza
  • B fragilis (cefotetan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cephalosporins: third generation

A

ceftriaxone
cefixime
cefotaxime
ceftazidime

activity:
- pneumonia
- meningitis
- gonorrhea
- broad activity(beta lactamase stable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cephalosporins: fourth generation

A

cefipime

activity:
-pseudomonas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cephalosporins: fifth generation

A

ceftaroline

activity:

  • skin
  • soft tissue
  • CA pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cephalosporins: PK

A

older: oral
newer: IV

renal elimination

THIRD GENERATION ENTER CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Cephalosporins: ADEs

A

hypersensitivity reactions

assume complete cross reactivity bt cephalosporins

1st generation: partial cross reactivity with PCNs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What cephalosporin is not given to newborns?

A

cetriaxone

-displaces bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Carbapenem

A

other beta lactam

imipenem-cilastatin (primaxin)
doripenem
meropenem
ertapenem

broad spectrum activity

  • PRSP (not MRSA)
  • gram negative rods
  • pseudomonas
ADEs: 
CNS effects (confusion, seizures)
26
Q

Monobactam

A

other beta lactam

aztreonam

no cross reactivity with beta lactams

activity:
gram negative bacteria
-klebsiella
-pseudomonas
-serratia 

ADEs:
CNS (HA, vertigo)

27
Q

Glycopeptides

A

vancomycin (MRSA, PRSP)

dalbavancin (skin)

oritavancin (skin)

telavancin (skin, HABP/VABP)

activity:
gram positive activity

28
Q

Glycopeptides: PK

A

parenteral for systemic infections

oral vancomycin for C difficile colitis

renal elimination

29
Q

Glycopeptides: toxicities

A

red neck/red man syndrome

  • erythematous rash on face, upper body
  • cause: infusion rate

nephrotoxicity (rare)

30
Q

Daptomycin

A

lipopeptide

PK: renal elimination

toxicity:
myopathy (weekly CPK/CK)

activity:
gram positive
-endocarditis, sepsis
-MSSA, MRSA

off label:

  • osteomyelitis
  • prosthetic joint infections
31
Q

Tetracycline (30S): agents

A

tetracycline
doxycycline
minocycline
tigecycline

32
Q

Tetracycline: activity spectrum

A
anthrax
chlamydial
mycoplasma
rickettsiae (RMSF, typhus)
spirochetes (lyme disease, relapse fever, syphilis)
H pylori
33
Q

Tetracycline: uses

A

acne
CAP, bronchitis
lyme disease
periodontitis

off label:

  • cellulitis (CA MRSA)
  • acute bacterial rhinosinusitis
34
Q

Tetracycline: ADEs

A

GI upset

interaction with di and trivalent ions

deposition in developing bones and teeth***

photosensitivity

35
Q

Macrolide (50S): agents

A

erythromycin
azithromycin (Z pak)
clarithromycin

36
Q

Macrolide: ADEs

A

GI upset

hepatic dysfunction

QT elongation

CYP450 (NOT azithromycin)

37
Q

Macrolide: activity spectrum

A

CAP
pertussis
corynebacteria (diphtheria)
chlamydial

38
Q

Lincosamdie (50S)

A

clindamycin

activity:

  • skin infections
  • soft tissue infections
  • anaerobic infections

ADE:
C difficile colitis

39
Q

Chloramphenicol (50S): ADEs

A

-dose related (aplastic) anemia

-gray baby
syndrome

symptoms:

  • circulatory collapse
  • cyanosis
  • acidosis
  • abdominal distention
  • myocardial depression
  • coma
  • death

risks:

  • serum levels >50mcg/ml
  • patients with impaired renal/hepatic function
40
Q

Chloramphenicol: activity spectrum

A

serious infections (resistant to less toxic abx)

  • bacteroides
  • H influenza
  • N meningitides
  • salmonella
  • rickettsia

active against many vancomycin resistant enterococci

41
Q

Oxazolidinone

A

binds to 23S RNA of 50S subunit

agent: linezolid

activity:

  • MRSA
  • PRSP
  • VRE strains

ADEs:

  • dose related anemia
  • neuropathy
  • optic neuritis
  • serotonin syndrome with SSRIs
42
Q

Aminoglycoside (30S): agents

A
gentamicin
tobramycin
amikacin
streptomycin
neomycin
43
Q

Aminoglycoside: activity spectrum

A

aerobic gram negative bacteria

H influenza

M catarrhalis

shigella

often used in combination with beta lactams

44
Q

Aminoglycoside: ADEs

A

nephrotoxicity
ototoxicity
neuromuscular blockade

45
Q

Antifolates: mechanism sulfonamide, trimethoprim

A

blockade of folic acid synthesis

sulfamethoxazole:

  • interferes with bacterial folic acid synthesis and growth
  • inhibition of dihydrofolic acid formation from para-aminonbenzoic acid

trimethoprim:

  • inhibits dihydrofolic acid reduction to tetrahydrofolate
  • sequential inhibition of enzymes of the folic acid pathway
46
Q

Antifolates: mechanism fluoroquinolones

A

interfere with bacterial DNA synthesis by inhibiting DNA gyrase

inhibits relaxation of supercoiled DNA

47
Q

Sulfonamides with Trimethoprim (Trimethoprim-sulfamethoxazole): activity spectrum

A
UTI
traveler's diarrhea
respiratory infections
ear infections
sinus infections
P jiroveci pneumonia (HIV)
toxoplasmosis (HIV)
nocardiosis
MSSA/MRSA skin soft tissue infections
48
Q

Sulfonamides with Trimethoprim: ADEs

A

rash
fever
bone marrow suppression
hyperkalemia

AIDs patients:

  • neutropenia
  • stevens johnson syndrome
  • toxic epidermal necrolysis
49
Q

What stage of pregnancy should TMP/SMX be avoided?

A

first trimester

after 32 weeks

50
Q

Quinolones: agents

A

ciprofloxacin

levofloxacin

gatifloxacin

gemfloxacin

moxifloxacin

ofloxacin

51
Q

Quinolones: activity spectrum

A

urogenital infections
GI tract infections
bacterial conjunctivitis

52
Q

Ciprofloxacin, ofloxacin: activity spectrum

A

UTIs

53
Q

Levofloxacin, gemfloxain, moxifloxacin: activity spectrum

A

respiratory flouroquinolones

gram positive cocci

atypicals (chlamydia, mycoplasma)

54
Q

Quinolones: ADEs

A
CNS effects (dizziness, HA)
tendinitis
peripheral neuropathy
neuromuscular blocking activity
QTc prolongation (levofloxacin, gemifloxacin, moxifloxacin)
55
Q

Quinolones: interaction

A

oral absorption impaired by cations (Ca, Mg, Al)

caution with use of class IA and III antiarrhythmic

56
Q

In what neuromuscular disease should quinolones be avoided?

A

MYASTHENIA GRAVIS

because they disrupt neuromuscular transmission

also be wary of macrolides

57
Q

Synergism

A

inhibitory/killing effects of 2+ antimicrobials used together are significantly greater than expected (than when used individually)

fourfold+ reduction in MIC or MBC of each drug

58
Q

Empiric Treatment

A

antimicrobial agent used before pathogen is identified for particular illness or susceptibility is known

59
Q

Guided Treatment

A

effective antimicrobial agent identified by susceptibility testing of infecting microorganism

60
Q

Before you prescribe…

A
allergy/hx of ADEs
age 
pregnancy
metabolic/genetic variation
renal/hepatic function
concomitant drug therapy
concomitant disease states
61
Q

Antibiogram

A

report of susceptibility/resistance of pathogens to antibiotics

information about local resistance patterns

used to determine empiric treatment options